[go: up one dir, main page]

WO2008003925A3 - Complement protein - Google Patents

Complement protein Download PDF

Info

Publication number
WO2008003925A3
WO2008003925A3 PCT/GB2007/002334 GB2007002334W WO2008003925A3 WO 2008003925 A3 WO2008003925 A3 WO 2008003925A3 GB 2007002334 W GB2007002334 W GB 2007002334W WO 2008003925 A3 WO2008003925 A3 WO 2008003925A3
Authority
WO
WIPO (PCT)
Prior art keywords
protein
complement protein
complement
insp191
termed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB2007/002334
Other languages
French (fr)
Other versions
WO2008003925A2 (en
Inventor
Richard Joseph Fagan
Stephen Noel Fitzgerald
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ares Trading SA
Original Assignee
Ares Trading SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading SA filed Critical Ares Trading SA
Publication of WO2008003925A2 publication Critical patent/WO2008003925A2/en
Publication of WO2008003925A3 publication Critical patent/WO2008003925A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/472—Complement proteins, e.g. anaphylatoxin, C3a, C5a

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

This invention relates to a protein, termed INSP191, herein identified as a secreted protein, in particular, as a complement protein and to the use of this protein and nucleic acid sequence from the encoding gene in the diagnosis, prevention and treatment of disease.
PCT/GB2007/002334 2006-07-06 2007-06-25 Complement protein Ceased WO2008003925A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0613471A GB0613471D0 (en) 2006-07-06 2006-07-06 Protein
GB0613471.2 2006-07-06

Publications (2)

Publication Number Publication Date
WO2008003925A2 WO2008003925A2 (en) 2008-01-10
WO2008003925A3 true WO2008003925A3 (en) 2008-02-28

Family

ID=36926595

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2007/002334 Ceased WO2008003925A2 (en) 2006-07-06 2007-06-25 Complement protein

Country Status (2)

Country Link
GB (1) GB0613471D0 (en)
WO (1) WO2008003925A2 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001081578A2 (en) * 2000-04-26 2001-11-01 Curagen Corporation Novel proteins and nucleic acids encoding same
WO2002102321A2 (en) * 2001-06-18 2002-12-27 Curagen Corporation Novel proteins and nucleic acids encoding same
US20040029220A1 (en) * 2000-04-26 2004-02-12 Vernet Corine A.M. Novel proteins and nucleic acids encoding same
WO2005049806A2 (en) * 2003-03-14 2005-06-02 Nuvelo, Inc. Novel nucleic acids and polypeptides

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001081578A2 (en) * 2000-04-26 2001-11-01 Curagen Corporation Novel proteins and nucleic acids encoding same
US20040029220A1 (en) * 2000-04-26 2004-02-12 Vernet Corine A.M. Novel proteins and nucleic acids encoding same
WO2002102321A2 (en) * 2001-06-18 2002-12-27 Curagen Corporation Novel proteins and nucleic acids encoding same
WO2005049806A2 (en) * 2003-03-14 2005-06-02 Nuvelo, Inc. Novel nucleic acids and polypeptides

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SAHU A ET AL: "Structure and biology of complement protein C3, a connecting link between innate and acquired immunity", IMMUNOLOGICAL REVIEWS, MUNKSGAARD, vol. 180, April 2001 (2001-04-01), pages 35 - 48, XP002962792, ISSN: 0105-2896 *

Also Published As

Publication number Publication date
WO2008003925A2 (en) 2008-01-10
GB0613471D0 (en) 2006-08-16

Similar Documents

Publication Publication Date Title
WO2007095316A3 (en) Compositions and methods for oligonucleotide formulations
WO2007117438A3 (en) Methods for the production of functional protein from dna having a nonsense mutation and the treatment of disorders associated therewith
WO2008088524A3 (en) Thrombospondin-domain-deficient r-spondin 1 protein as gastrointestinal tract epithelial proliferation factor
WO2008095622A3 (en) SECRETED LUCIFERASE MLuc7 AND USE THEREOF
WO2006128041A3 (en) Compositions and methods for the treatment or prevention of chemoresistant neoplasia
WO2008015380A3 (en) Integral membrane protein of the pmp-22/emp/mp20/ claudin-like family
IL169367A0 (en) Defensin proteins
WO2006046073A3 (en) C1q related protein
WO2006016172A3 (en) Cell surface glycoprotein
WO2006122971A3 (en) Treatment of disease using an improved regulated expression system
WO2006043060A3 (en) Mam domain containing protein
WO2008003925A3 (en) Complement protein
WO2004056983A3 (en) Metalloprotease proteins
WO2008001045A8 (en) Members of the glycoside hydrolase family 31 family of proteins
WO2007049065A3 (en) Vwfa, collagen and kunitz domain containing protein
WO2004101618A3 (en) Progestin-yol002c-cgi-45 receptor-related proteins
WO2006051333A3 (en) Leucine-rich repeat (lrr) motif containing proteins
WO2008012505A3 (en) Gpi-anchored cell surface glycoprotein
WO2008033374A3 (en) Ocl-2a3 compositions and uses thereof
WO2004081170A3 (en) Progestin receptor-like protein
WO2007049062A3 (en) Vwfa-domain containing proteins
WO2007068913A3 (en) SRCR-B Domain Containing Proteins
MXPA05012414A (en) Tnf-like secreted protein.
GB0613470D0 (en) Protein
WO2003066844A3 (en) Cytochrome p450 protein

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07733329

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 07733329

Country of ref document: EP

Kind code of ref document: A2